1. Home
  2. ABCL vs OMCL Comparison

ABCL vs OMCL Comparison

Compare ABCL & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • OMCL
  • Stock Information
  • Founded
  • ABCL 2012
  • OMCL 1992
  • Country
  • ABCL Canada
  • OMCL United States
  • Employees
  • ABCL N/A
  • OMCL N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • OMCL Computer Manufacturing
  • Sector
  • ABCL Health Care
  • OMCL Technology
  • Exchange
  • ABCL Nasdaq
  • OMCL Nasdaq
  • Market Cap
  • ABCL 1.1B
  • OMCL 1.3B
  • IPO Year
  • ABCL 2020
  • OMCL 2001
  • Fundamental
  • Price
  • ABCL $4.01
  • OMCL $28.69
  • Analyst Decision
  • ABCL Strong Buy
  • OMCL Buy
  • Analyst Count
  • ABCL 5
  • OMCL 6
  • Target Price
  • ABCL $7.50
  • OMCL $44.83
  • AVG Volume (30 Days)
  • ABCL 6.8M
  • OMCL 415.8K
  • Earning Date
  • ABCL 08-07-2025
  • OMCL 07-31-2025
  • Dividend Yield
  • ABCL N/A
  • OMCL N/A
  • EPS Growth
  • ABCL N/A
  • OMCL N/A
  • EPS
  • ABCL N/A
  • OMCL 0.45
  • Revenue
  • ABCL $23,114,000.00
  • OMCL $1,135,755,000.00
  • Revenue This Year
  • ABCL N/A
  • OMCL $3.84
  • Revenue Next Year
  • ABCL $67.99
  • OMCL $3.98
  • P/E Ratio
  • ABCL N/A
  • OMCL $63.65
  • Revenue Growth
  • ABCL N/A
  • OMCL 3.00
  • 52 Week Low
  • ABCL $1.89
  • OMCL $22.66
  • 52 Week High
  • ABCL $4.33
  • OMCL $55.75
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 65.36
  • OMCL 43.98
  • Support Level
  • ABCL $3.28
  • OMCL $28.81
  • Resistance Level
  • ABCL $4.33
  • OMCL $30.19
  • Average True Range (ATR)
  • ABCL 0.30
  • OMCL 0.88
  • MACD
  • ABCL 0.02
  • OMCL 0.02
  • Stochastic Oscillator
  • ABCL 71.17
  • OMCL 34.49

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About OMCL Omnicell Inc. ($0.001 par value)

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

Share on Social Networks: